176 related articles for article (PubMed ID: 23400555)
1. Risk of pancreatic cancer in relation to ABO blood group and hepatitis C virus infection in Korea: a case-control study.
Woo SM; Joo J; Lee WJ; Park SJ; Han SS; Kim TH; Koh YH; Kim HB; Hong EK
J Korean Med Sci; 2013 Feb; 28(2):247-51. PubMed ID: 23400555
[TBL] [Abstract][Full Text] [Related]
2. ABO blood group, hepatitis B viral infection and risk of pancreatic cancer.
Wang DS; Chen DL; Ren C; Wang ZQ; Qiu MZ; Luo HY; Zhang DS; Wang FH; Li YH; Xu RH
Int J Cancer; 2012 Jul; 131(2):461-8. PubMed ID: 21858814
[TBL] [Abstract][Full Text] [Related]
3. [The relationship between hepatitis B virus infection and the incidence of pancreatic cancer: a retrospective case-control study].
Hong SG; Kim JH; Lee YS; Yoon E; Lee HJ; Hwang JK; Jung ES; Joo MK; Jung YK; Yeon JE; Park JJ; Kim JS; Bak YT; Byun KS
Korean J Hepatol; 2010 Mar; 16(1):49-56. PubMed ID: 20375642
[TBL] [Abstract][Full Text] [Related]
4. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
[TBL] [Abstract][Full Text] [Related]
5. Association between hepatitis B virus and pancreatic cancer.
Hassan MM; Li D; El-Deeb AS; Wolff RA; Bondy ML; Davila M; Abbruzzese JL
J Clin Oncol; 2008 Oct; 26(28):4557-62. PubMed ID: 18824707
[TBL] [Abstract][Full Text] [Related]
6. Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study.
Oh JK; Shin HR; Lim MK; Cho H; Kim DI; Jee Y; Yun H; Yoo KY
BMC Cancer; 2012 Oct; 12():452. PubMed ID: 23039099
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis virus B and C infections are associated with an increased risk of non-Hodgkin lymphoma: A nested case-control study using a national sample cohort.
Kim M; Lee YK; Park B; Oh DJ; Choi HG
J Med Virol; 2020 Aug; 92(8):1214-1220. PubMed ID: 31825111
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter study.
Loras C; Saro C; Gonzalez-Huix F; Mínguez M; Merino O; Gisbert JP; Barrio J; Bernal A; Gutiérrez A; Piqueras M; Calvet X; Andreu M; Abad A; Ginard D; Bujanda L; Panés J; Torres M; Fernández-Bañares F; Viver JM; Esteve M;
Am J Gastroenterol; 2009 Jan; 104(1):57-63. PubMed ID: 19098850
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of risk factors for extrahepatic cholangiocarcinoma: ABO blood group, hepatitis B virus and their synergism.
Zhou Y; Zhou Q; Lin Q; Chen R; Gong Y; Liu Y; Yu M; Zeng B; Li K; Chen R; Li Z
Int J Cancer; 2013 Oct; 133(8):1867-75. PubMed ID: 23564396
[TBL] [Abstract][Full Text] [Related]
10. Serological prevalence of hepatitis B virus and hepatitis C virus infection in the elderly population: Polish nationwide survey--PolSenior.
Hartleb M; Gutkowski K; Zejda JE; Chudek J; Więcek A
Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1288-95. PubMed ID: 22864260
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B and C Virus Infection and Risk of Pancreatic Cancer: A Population-Based Cohort Study (JPHC Study Cohort II).
Krull Abe S; Inoue M; Sawada N; Iwasaki M; Shimazu T; Yamaji T; Sasazuki S; Saito E; Tanaka Y; Mizokami M; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2016 Mar; 25(3):555-7. PubMed ID: 26715423
[TBL] [Abstract][Full Text] [Related]
12. Distribution of ABO/Rh blood groups and their association with hepatitis B virus infection in 3.8 million Chinese adults: A population-based cross-sectional study.
Liu J; Zhang S; Liu M; Wang Q; Shen H; Zhang Y
J Viral Hepat; 2018 Apr; 25(4):401-411. PubMed ID: 29193618
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B and hepatitis C seroprevalence in children receiving antiretroviral therapy for human immunodeficiency virus-1 infection in China, 2005-2009.
Zhou S; Zhao Y; He Y; Li H; Bulterys M; Sun X; Dou Z; Robinson M; Zhang F
J Acquir Immune Defic Syndr; 2010 Jun; 54(2):191-6. PubMed ID: 20032784
[TBL] [Abstract][Full Text] [Related]
14. Viral hepatitis and HIV-associated tuberculosis: risk factors and TB treatment outcomes in Thailand.
Sirinak C; Kittikraisak W; Pinjeesekikul D; Charusuntonsri P; Luanloed P; Srisuwanvilai LO; Nateniyom S; Akksilp S; Likanonsakul S; Sattayawuthipong W; Burapat C; Varma JK
BMC Public Health; 2008 Jul; 8():245. PubMed ID: 18638392
[TBL] [Abstract][Full Text] [Related]
15. Effects of hepatitis C and B viruses infection on the development of hepatocellular carcinoma.
Tsai JF; Chang WY; Jeng JE; Ho MS; Lin ZY; Tsai JH
J Med Virol; 1994 Sep; 44(1):92-5. PubMed ID: 7528262
[TBL] [Abstract][Full Text] [Related]
16. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
[TBL] [Abstract][Full Text] [Related]
17. Mutual confounding and interactive effects between hepatitis C and hepatitis B viral infections in hepatocellular carcinogenesis: a population-based case-control study in Taiwan.
Sun CA; Farzadegan H; You SL; Lu SN; Wu MH; Wolfe L; Hardy W; Huang GT; Yang PM; Lee H; Chen CJ
Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):173-8. PubMed ID: 8833617
[TBL] [Abstract][Full Text] [Related]
18. ABO Blood Group and Diabetes Mellitus Influence the Risk for Pancreatic Cancer in a Population from China.
Li X; Xu H; Gao P
Med Sci Monit; 2018 Dec; 24():9392-9398. PubMed ID: 30582832
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma in Egyptians with and without a history of hepatitis B virus infection: association with hepatitis C virus (HCV) infection but not with (HCV) RNA level.
Yates SC; Hafez M; Beld M; Lukashov VV; Hassan Z; Carboni G; Khaled H; McMorrow M; Attia M; Goudsmit J
Am J Trop Med Hyg; 1999 Apr; 60(4):714-20. PubMed ID: 10348253
[TBL] [Abstract][Full Text] [Related]
20. [Detection of hepatitis B and hepatitis C markers in HIV positive patients, 2000-2004].
Bello Corredor M; Rodríguez Lay Lde L; Gutiérrez Moreno A; Sariego Frómeta S; Montalvo Villalba MC; Sánchez Sol A
Rev Cubana Med Trop; 2005; 57(3):212-3. PubMed ID: 17969276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
